The Future of Quality and Maintaining a Reliable Supply Chain
Monday, October 27, 2025
1:15 p.m. - 2:30 p.m.
Tools and processes to assure the supply of high-quality, safe, and effective drugs are evolving. This session will explore various possible solutions that could improve both the quality and supply of generic and biosimilar medicines, including Quality Management Maturity (QMM), processes and policies related to inspections and surveillance, guidances, and marketplace dynamics.
Participants:
Djamila Harouaka, PhD
Senior Scientific Advisor, Office of Quality Surveillance (OQS), OPQ, CDER, FDA
Mayank Nagar, M.S., MBA
Vice President & Head of Technical Services and Product Launch Management, Dr. Reddy’s Laboratories Inc.
Jude Nwokike, PhD, MSc, MPH, B. Pharm
Vice President, Supply Chain Resilience, USP
Head of Supply Chain – North America, Sun Pharma
Senior Director, Occ & Env Hlth Sciences, Environment, Health, Safety and Sustainability, Teva Pharmaceuticals
